Continued Treatment for Participants Enrolled in Studies of BXQ-350
Clinical trial NCT04404569 · TERMINATED
Trial details
- NCT number
- NCT04404569
- Sponsor
- Bexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-08
- Primary completion
- 2024-09-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.